Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding

Background: Patients with liver cirrhosis and gastrointestinal bleeding (GIB) often develop anemia. Ferric carboxymaltose (FCM) is an intravenous (i.v.) iron formulation approved for use in patients with iron deficiency with inadequate response to oral iron therapy or when oral iron cannot be used....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Med (Lausanne)
Main Authors: Ballester-Clau, Raquel, Torres Vicente, Gisela, Cucala Ramos, Mercedes, Aracil Blanch, Carles, Miñana Calafat, Josep Maria, Pijoan Comas, Eva, Reñé Espinet, Josep Maria, Planella de Rubinat, Montse
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7181670/
https://ncbi.nlm.nih.gov/pubmed/32363194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00128
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares